Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers
Clinical trial NCT04160065 · COMPLETED
Trial details
- NCT number
- NCT04160065
- Sponsor
- TuHURA Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-03
- Primary completion
- 2023-10-19
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.